• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剂量率对舌活动部和口底T1-2期鳞状细胞癌采用铱-192组织间插植进行根治性放疗时局部控制及并发症的影响

Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192.

作者信息

Mazeron J J, Simon J M, Le Péchoux C, Crook J M, Grimard L, Piedbois P, Le Bourgeois J P, Pierquin B

机构信息

Département de Cancérologie, Hôpital Henri Mondor, Créteil, France.

出版信息

Radiother Oncol. 1991 May;21(1):39-47. doi: 10.1016/0167-8140(91)90339-i.

DOI:10.1016/0167-8140(91)90339-i
PMID:1852918
Abstract

From 1971 to 1988, 134 T1 and 145 T2 biopsy-proven squamous cell carcinomas of mobile tongue and floor of mouth were definitively managed by iridium-192. Implantations were performed using either guide gutters or afterloading plastic catheters. The prescribed dose at the reference isodose (85% of the basal dose rate, Paris system) was 60-70 Gy. Total dose was not adjusted to dose rate or tumor volume. Results of the 279 implants have been analysed to look for a possible influence of dose rate on local control and necrosis. Follow-up patients free of local recurrence is 1-180 months with average of 51 months. The 279 tumors were divided in four groups according to dose and dose rate: greater than or equal to 62.5 Gy and greater than or equal to 0.5 Gy/h (n = 130), greater than or equal to 62.5 Gy and less than 0.5 Gy/h (n = 36), less than 62.5 Gy and greater than or equal to 0.5 Gy/h (n = 81), less than 62.5 Gy and less than 0.5 Gy/h (n = 32). The four groups were comparable according to age, sex, tumor diameter and macroscopic aspect. At 5 years, the estimated local control (Kaplan Meier) was 93, 87, 79 and 52%, respectively (dose adjusted to dose rate: p less than 0.001, dose rate adjusted to dose: p less than 0.01, Log-rank); the necrosis rate was 44, 24, 37 and 5%, respectively (dose adjusted to dose rate: p = 0.08, dose rate adjusted to dose: p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

1971年至1988年期间,134例经活检证实为T1期、145例为T2期的活动期舌癌和口底鳞状细胞癌采用铱-192进行了明确治疗。植入操作使用导向槽或后装塑料导管进行。参考等剂量线(巴黎系统基础剂量率的85%)处的处方剂量为60 - 70 Gy。总剂量未根据剂量率或肿瘤体积进行调整。对这279例植入治疗的结果进行了分析,以寻找剂量率对局部控制和坏死的可能影响。随访无局部复发的患者时间为1 - 180个月,平均51个月。根据剂量和剂量率,这279个肿瘤被分为四组:大于或等于62.5 Gy且大于或等于0.5 Gy/h(n = 130),大于或等于62.5 Gy且小于0.5 Gy/h(n = 36),小于62.5 Gy且大于或等于0.5 Gy/h(n = 81),小于62.5 Gy且小于0.5 Gy/h(n = 32)。这四组在年龄、性别、肿瘤直径和宏观表现方面具有可比性。5年时,估计的局部控制率(Kaplan - Meier法)分别为93%、87%、79%和52%(剂量根据剂量率调整:p < 0.00I,剂量率根据剂量调整:p < 0.01,对数秩检验);坏死率分别为44%、24%、37%和5%(剂量根据剂量率调整:p = 0.08,剂量率根据剂量调整:p < 0.01)。(摘要截短为250字)

相似文献

1
Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192.剂量率对舌活动部和口底T1-2期鳞状细胞癌采用铱-192组织间插植进行根治性放疗时局部控制及并发症的影响
Radiother Oncol. 1991 May;21(1):39-47. doi: 10.1016/0167-8140(91)90339-i.
2
Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth.源间间距对活动期舌癌及口底癌近距离放射治疗局部控制和并发症的影响
Radiother Oncol. 1993 Jan;26(1):19-25. doi: 10.1016/0167-8140(93)90021-y.
3
[Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch].[铱192植入在腭咽弓T1-T2鳞状细胞癌放疗中的植入部位]
Bull Cancer Radiother. 1996;83(1):47-53.
4
Place of Iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas.
Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):251-7. doi: 10.1016/0360-3016(93)90235-n.
5
Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins.对于切缘接近或阳性的口腔舌部和口底T1-2 N0鳞状细胞癌,单纯术后近距离放射治疗。
Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):37-42. doi: 10.1016/s0360-3016(00)00538-1.
6
Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation.铱192植入治疗口腔舌部T1、T2期癌局部预后的相关因素
Int J Radiat Oncol Biol Phys. 1990 Aug;19(2):281-5. doi: 10.1016/0360-3016(90)90535-r.
7
Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth.舌活动部和/或口底I期和II期癌的放射治疗。
Radiother Oncol. 1994 Jun;31(3):199-206. doi: 10.1016/0167-8140(94)90424-3.
8
Treatment of squamous cell carcinomas of the floor of the mouth and tongue by interstitial high-dose-rate irradiation using iridium-192.使用铱-192进行组织间高剂量率照射治疗口腔底部和舌部鳞状细胞癌。
Int J Oral Maxillofac Surg. 1998 Feb;27(1):45-8. doi: 10.1016/s0901-5027(98)80095-7.
9
Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue.可动性舌部T1和T2期癌的铱192植入治疗
Int J Radiat Oncol Biol Phys. 1990 Dec;19(6):1369-76. doi: 10.1016/0360-3016(90)90346-l.
10
Squamous cell carcinoma of the oral tongue and floor of mouth. Evaluation of interstitial radium therapy.口腔舌部和口底鳞状细胞癌。间质镭疗评估。
AJR Am J Roentgenol. 1976 Feb;126(2):223-8. doi: 10.2214/ajr.126.2.223.

引用本文的文献

1
Comparison of dose calculation approaches and clinical dose-response in image-guided head&neck brachytherapy of the oral cavity.口腔图像引导头颈部近距离放射治疗中剂量计算方法与临床剂量反应的比较
Clin Transl Radiat Oncol. 2025 May 8;53:100968. doi: 10.1016/j.ctro.2025.100968. eCollection 2025 Jul.
2
Dose Rate Effects from the 1950s through to the Era of FLASH.从 20 世纪 50 年代到 FLASH 时代的剂量率效应。
Radiat Res. 2024 Aug 1;202(2):161-176. doi: 10.1667/RADE-24-00024.1.
3
Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines.
头颈部恶性肿瘤的近距离放射治疗:印度近距离放射治疗协会(IBS)建议与指南
J Contemp Brachytherapy. 2020 Oct;12(5):501-511. doi: 10.5114/jcb.2020.100385. Epub 2020 Oct 30.
4
Comparison of radiobiological parameters for Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro.体外Y放射性核素治疗(RNT)与外照射放疗(EBRT)的放射生物学参数比较。
EJNMMI Phys. 2018 Sep 3;5(1):18. doi: 10.1186/s40658-018-0217-8.
5
High-dose-rate and pulsed-dose-rate brachytherapy for oral cavity cancer and oropharynx cancer.口腔癌和口咽癌的高剂量率及脉冲剂量率近距离放射治疗。
J Contemp Brachytherapy. 2009 Dec;1(4):216-223. Epub 2010 Jan 13.
6
Evaluation of neuropathic pain occurring after high-dose-rate interstitial brachytherapy of oral tongue.口腔舌部高剂量率组织间近距离放疗后发生的神经性疼痛的评估
J Contemp Brachytherapy. 2015 Apr;7(2):142-6. doi: 10.5114/jcb.2015.50658. Epub 2015 Apr 1.
7
Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy.现代头颈部近距离放射治疗:从镭到调强介入性近距离放射治疗。
J Contemp Brachytherapy. 2015 Jan;6(4):404-16. doi: 10.5114/jcb.2014.47813. Epub 2014 Dec 31.
8
Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.头颈部癌高剂量适形放疗靶区勾画中风险与获益的权衡
Semin Radiat Oncol. 2009 Jan;19(1):43-52. doi: 10.1016/j.semradonc.2008.09.008.
9
Intracavitary brachytherapy for carcinoma of the uterine cervix--comparison of HDR (Ir-192) and MDR (Cs-137).子宫颈癌腔内近距离放射治疗——高剂量率(铱-192)与中剂量率(铯-137)的比较
Radiat Med. 2006 Jan;24(1):50-7. doi: 10.1007/BF02489989.
10
[Salvage therapy of advanced squamous cell carcinoma of the mouth cavity and oropharynx. Results of interstitial high-dose-rate brachytherapy combined with ablative tumor surgery].[口腔和口咽晚期鳞状细胞癌的挽救治疗。高剂量率组织间近距离放疗联合肿瘤切除手术的结果]
Strahlenther Onkol. 1997 Oct;173(10):507-12. doi: 10.1007/BF03038466.